13F-HR filed by Stonepine Capital Management, LLC
Stonepine Capital Management, LLC filed this 13F-HR for the quarter ended 2024-12-31, filed 2025-02-14, with 52 holding rows worth $123,887,533.
- Accession
- 0000935836-25-000151
- Filer
- CIK 1440771
- Filed
- 2025-02-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2024
A holdings report, 52 entries on the cover page, a total value of $123,887,533 stated on the cover page (in dollars after the unit check, H1), rows summing to $123,887,533 with VALUE read as dollars as filed, 13F file number 028-17175. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| ADMA BIOLOGICS INC | 000899104 | COM | 1,241,032 | $21,283,699 | dollars as filed | |
| EVOLUS INC | 30052C107 | COM | 1,264,651 | $13,961,747 | dollars as filed | |
| TELA BIO INC | 872381108 | COM | 2,353,099 | $7,106,359 | dollars as filed | |
| LAKEFRONT BIOTHERAPEUTICS NV | 36315X101 | SPON ADR | 200,000 | $5,500,000 | dollars as filed | |
| ZEVRA THERAPEUTICS INC COM NEW | 488445206 | Stock | 597,700 | $4,984,818 | dollars as filed | |
| VERASTEM INC | 92337C203 | COMMON STOCK | 870,000 | $4,497,900 | dollars as filed | |
| ACADIA PHARMACEUTICALS INC | 004225108 | COM | 220,000 | $4,037,000 | dollars as filed | |
| OPTINOSE INC | 68404V209 | COM | 588,657 | $3,932,229 | dollars as filed | |
| ANIKA THERAPEUTICS INC | 035255108 | COM | 238,222 | $3,921,134 | dollars as filed | |
| Indivior PLC | G4766E116 | Common Stock | 305,000 | $3,791,150 | dollars as filed | |
| ESTABLISHMENT LABS HOLDINGS | G31249108 | COMMON STOCK | 80,002 | $3,685,692 | dollars as filed | |
| INHIBIKASE THERAPEUTICS INC | 45719W205 | COMMON STOCK | 1,132,388 | $3,680,261 | dollars as filed | |
| UROGEN PHARMA LTD | M96088105 | COMMON STOCK | 324,324 | $3,454,051 | dollars as filed | |
| XOMA ROYALTY CORPORATION | 98419J206 | COMMON STOCK | 125,700 | $3,303,396 | dollars as filed | |
| Day One Biopharmaceuticals Inc | 23954D109 | Common Stock | 235,000 | $2,977,450 | dollars as filed | |
| IRONWOOD PHARMACEUTICALS INC | 46333X108 | COMMON STOCK | 648,785 | $2,874,118 | dollars as filed | |
| SCPHARMACEUTICALS INC | 810648105 | COM | 683,530 | $2,419,696 | dollars as filed | |
| SURROZEN INC | 86889P208 | COMMON STOCK | 137,200 | $1,968,820 | dollars as filed | |
| INOVIO PHARMACEUTICALS I | 45773H409 | COMMON STOCK | 1,050,000 | $1,921,500 | dollars as filed | |
| ENANTA PHARMACEUTICALS INC | 29251M106 | COM | 331,900 | $1,908,425 | dollars as filed | |
| MYOMO INC | 62857J201 | COM NEW | 274,426 | $1,767,303 | dollars as filed | |
| CALCIMEDICA INC | 38942Q202 | COM NEW | 468,793 | $1,659,527 | dollars as filed | |
| ACLARIS THERAPEUTICS INC COM | 00461U105 | Stock | 663,405 | $1,645,244 | dollars as filed | |
| PROFOUND MED CORP | 74319B502 | COM NEW | 200,000 | $1,502,000 | dollars as filed | |
| JAZZ PHARMACEUTICALS PLC SHS USD | G50871105 | Stock | 10,000 | $1,231,500 | dollars as filed | |
| VIR BIOTECHNOLOGY INC | 92764N102 | COM | 164,106 | $1,204,538 | dollars as filed | |
| Milestone Pharmaceuticals Inc | 59935V107 | COM | 500,000 | $1,180,000 | dollars as filed | |
| ANI PHARMACEUTICALS INC | 00182C103 | COM | 20,400 | $1,127,712 | dollars as filed | |
| HERON THERAPEUTICS INC | 427746102 | COM | 700,000 | $1,071,000 | dollars as filed | |
| EXAGEN INC | 30068X103 | COM | 251,049 | $1,029,301 | dollars as filed | |
| 2SEVENTY BIO INC COMMON STOCK | 901384107 | Stock | 300,000 | $882,000 | dollars as filed | |
| ITEOS THERAPEUTICS INC | 46565G104 | COM | 110,000 | $844,800 | dollars as filed | |
| PMV PHARMACEUTICALS INC | 69353Y103 | COM | 535,805 | $809,066 | dollars as filed | |
| KEZAR LIFE SCIENCES INC | 49372L209 | COM NEW | 110,000 | $739,200 | dollars as filed | |
| AYTU BIOPHARMA INC | 054754858 | COM | 407,549 | $692,833 | dollars as filed | |
| ADICET BIO INC | 007002108 | COM | 700,000 | $673,400 | dollars as filed | |
| KIORA PHARMACEUTICALS INC | 49721T507 | COM | 200,970 | $663,201 | dollars as filed | |
| XERIS BIOPHARMA HOLDINGS INC | 98422E103 | COM | 182,317 | $618,055 | dollars as filed | |
| AQUESTIVE THERAPEUTICS INC COM | 03843E104 | Stock | 160,000 | $569,600 | dollars as filed | |
| APREA THERAPEUTICS INC | 03836J201 | COM NEW | 149,221 | $490,937 | dollars as filed | |
| ACELYRIN INC | 00445A100 | COM | 132,870 | $417,212 | dollars as filed | |
| COHERUS ONCOLOGY INC | 19249H103 | COM | 250,000 | $345,000 | dollars as filed | |
| POLYPID LTD | M8001Q126 | COM | 103,668 | $315,151 | dollars as filed | |
| HILLEVAX INC | 43157M102 | COM | 132,347 | $273,958 | dollars as filed | |
| AN2 THERAPEUTICS INC | 037326105 | COM | 196,732 | $271,490 | dollars as filed | |
| VANDA PHARMACEUTICALS INC | 921659108 | COM | 25,000 | $119,750 | dollars as filed | |
| ELEVATION ONCOLOGY INC COM | 28623U101 | Stock | 200,000 | $112,520 | dollars as filed | |
| ABIVAX SA- | 00370M103 | SPONSORED ADS | 15,000 | $109,800 | dollars as filed | |
| ALIMERA SCIENCES INC CVR | 016CVR029 | COM | 2,408,469 | $107,124 | dollars as filed | |
| ALLARITY THERAPEUTICS INC | 016744500 | COM | 67,289 | $78,728 | dollars as filed | |
| REVANCE THERAPEUTICS INC | 761330109 | COM | 23,264 | $70,723 | dollars as filed | |
| AMARIN CORP PLC | 023111206 | SPONS ADR NEW | 114,257 | $55,415 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0000935836-25-000151 | this filing | 2025-02-14 | acceptance time not in the bulk data set |